Clinical trial
A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)
NCT05094336
Study timeline
Study start (actual)2022-02-01Date precision: day
Registry last updated2026-05-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced MTAP-null Solid Tumorsunresolved
Interventions
Sponsors & collaborators
Amgenlead sponsor
Mapped research locations
SeoulSouth Korea3HoustonTexas, United States2PhiladelphiaPennsylvania, United States2IndianapolisIndiana, United States2ShanghaiShanghai Municipality, China2TaipeiTaiwan2FuzhouFujian, China2New YorkNew York, United States1DallasTexas, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1TorontoOntario, Canada1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05094336 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.